NCT00950638View on ClinicalTrials.gov

A Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

July 16, 2009

Primary Completion Date

March 24, 2011

Study Completion Date

March 24, 2011

Conditions
Dry Age-Related Macular Degeneration
Interventions
DRUG

Avacincaptad Pegol

intravitreal injection

Trial Locations (1)

Unknown

Ophthotech, New York

Sponsors
All Listed Sponsors
lead

Ophthotech Corporation

INDUSTRY

NCT00950638 - A Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration | Biotech Hunter | Biotech Hunter